FDA-2026-P-4819

Request that FDA create a universal nonprescription-access policy for all human drugs approved under section 505 of the Federal Food, Drug, and Cosmetic Act, with one categorical exclusion: a drug containing an active ingredient listed in Schedule I through V under the Controlled Substances Act